Regenerative Medicine Products - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509246114

Publication Date:

September 10, 2024

Pages:

162

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Regenerative Medicine Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Regenerative Medicine Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Regenerative Medicine Products by region & country, by Type, and by Application.
The Regenerative Medicine Products market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Medicine Products.
麻豆原创 Segmentation
By Company
Acelity
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori Therapeutics
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologes
Bellicum Pharmaceuticals
Segment by Type:
Cell Therapy
Tissue Engineering
Biomaterial
Others
Segment by Application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Regenerative Medicine Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Regenerative Medicine Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Regenerative Medicine Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Regenerative Medicine Products Product Introduction
1.2 Global Regenerative Medicine Products 麻豆原创 Size Forecast
1.2.1 Global Regenerative Medicine Products Sales Value (2019-2030)
1.2.2 Global Regenerative Medicine Products Sales Volume (2019-2030)
1.2.3 Global Regenerative Medicine Products Sales Price (2019-2030)
1.3 Regenerative Medicine Products 麻豆原创 Trends & Drivers
1.3.1 Regenerative Medicine Products Industry Trends
1.3.2 Regenerative Medicine Products 麻豆原创 Drivers & Opportunity
1.3.3 Regenerative Medicine Products 麻豆原创 Challenges
1.3.4 Regenerative Medicine Products 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Regenerative Medicine Products Players Revenue Ranking (2023)
2.2 Global Regenerative Medicine Products Revenue by Company (2019-2024)
2.3 Global Regenerative Medicine Products Players Sales Volume Ranking (2023)
2.4 Global Regenerative Medicine Products Sales Volume by Company Players (2019-2024)
2.5 Global Regenerative Medicine Products Average Price by Company (2019-2024)
2.6 Key Manufacturers Regenerative Medicine Products Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Regenerative Medicine Products Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Regenerative Medicine Products
2.9 Regenerative Medicine Products 麻豆原创 Competitive Analysis
2.9.1 Regenerative Medicine Products 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Regenerative Medicine Products Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine Products as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cell Therapy
3.1.2 Tissue Engineering
3.1.3 Biomaterial
3.1.4 Others
3.2 Global Regenerative Medicine Products Sales Value by Type
3.2.1 Global Regenerative Medicine Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Regenerative Medicine Products Sales Value, by Type (2019-2030)
3.2.3 Global Regenerative Medicine Products Sales Value, by Type (%) (2019-2030)
3.3 Global Regenerative Medicine Products Sales Volume by Type
3.3.1 Global Regenerative Medicine Products Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Regenerative Medicine Products Sales Volume, by Type (2019-2030)
3.3.3 Global Regenerative Medicine Products Sales Volume, by Type (%) (2019-2030)
3.4 Global Regenerative Medicine Products Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Dermatology
4.1.2 Cardiovascular
4.1.3 CNS
4.1.4 Orthopedic
4.1.5 Others
4.2 Global Regenerative Medicine Products Sales Value by Application
4.2.1 Global Regenerative Medicine Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Regenerative Medicine Products Sales Value, by Application (2019-2030)
4.2.3 Global Regenerative Medicine Products Sales Value, by Application (%) (2019-2030)
4.3 Global Regenerative Medicine Products Sales Volume by Application
4.3.1 Global Regenerative Medicine Products Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Regenerative Medicine Products Sales Volume, by Application (2019-2030)
4.3.3 Global Regenerative Medicine Products Sales Volume, by Application (%) (2019-2030)
4.4 Global Regenerative Medicine Products Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Regenerative Medicine Products Sales Value by Region
5.1.1 Global Regenerative Medicine Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Regenerative Medicine Products Sales Value by Region (2019-2024)
5.1.3 Global Regenerative Medicine Products Sales Value by Region (2025-2030)
5.1.4 Global Regenerative Medicine Products Sales Value by Region (%), (2019-2030)
5.2 Global Regenerative Medicine Products Sales Volume by Region
5.2.1 Global Regenerative Medicine Products Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Regenerative Medicine Products Sales Volume by Region (2019-2024)
5.2.3 Global Regenerative Medicine Products Sales Volume by Region (2025-2030)
5.2.4 Global Regenerative Medicine Products Sales Volume by Region (%), (2019-2030)
5.3 Global Regenerative Medicine Products Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Regenerative Medicine Products Sales Value, 2019-2030
5.4.2 North America Regenerative Medicine Products Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Regenerative Medicine Products Sales Value, 2019-2030
5.5.2 Europe Regenerative Medicine Products Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Regenerative Medicine Products Sales Value, 2019-2030
5.6.2 Asia Pacific Regenerative Medicine Products Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Regenerative Medicine Products Sales Value, 2019-2030
5.7.2 South America Regenerative Medicine Products Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Regenerative Medicine Products Sales Value, 2019-2030
5.8.2 Middle East & Africa Regenerative Medicine Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Regenerative Medicine Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Regenerative Medicine Products Sales Value
6.2.1 Key Countries/Regions Regenerative Medicine Products Sales Value, 2019-2030
6.2.2 Key Countries/Regions Regenerative Medicine Products Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Regenerative Medicine Products Sales Value, 2019-2030
6.3.2 United States Regenerative Medicine Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Regenerative Medicine Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Regenerative Medicine Products Sales Value, 2019-2030
6.4.2 Europe Regenerative Medicine Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Regenerative Medicine Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Regenerative Medicine Products Sales Value, 2019-2030
6.5.2 China Regenerative Medicine Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Regenerative Medicine Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Regenerative Medicine Products Sales Value, 2019-2030
6.6.2 Japan Regenerative Medicine Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Regenerative Medicine Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Regenerative Medicine Products Sales Value, 2019-2030
6.7.2 South Korea Regenerative Medicine Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Regenerative Medicine Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Regenerative Medicine Products Sales Value, 2019-2030
6.8.2 Southeast Asia Regenerative Medicine Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Regenerative Medicine Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Regenerative Medicine Products Sales Value, 2019-2030
6.9.2 India Regenerative Medicine Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Regenerative Medicine Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Acelity
7.1.1 Acelity Company Information
7.1.2 Acelity Introduction and Business Overview
7.1.3 Acelity Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Acelity Regenerative Medicine Products Product Offerings
7.1.5 Acelity Recent Development
7.2 DePuy Synthes
7.2.1 DePuy Synthes Company Information
7.2.2 DePuy Synthes Introduction and Business Overview
7.2.3 DePuy Synthes Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.2.4 DePuy Synthes Regenerative Medicine Products Product Offerings
7.2.5 DePuy Synthes Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Medtronic Regenerative Medicine Products Product Offerings
7.3.5 Medtronic Recent Development
7.4 ZimmerBiomet
7.4.1 ZimmerBiomet Company Information
7.4.2 ZimmerBiomet Introduction and Business Overview
7.4.3 ZimmerBiomet Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.4.4 ZimmerBiomet Regenerative Medicine Products Product Offerings
7.4.5 ZimmerBiomet Recent Development
7.5 Stryker
7.5.1 Stryker Company Information
7.5.2 Stryker Introduction and Business Overview
7.5.3 Stryker Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Stryker Regenerative Medicine Products Product Offerings
7.5.5 Stryker Recent Development
7.6 MiMedx Group
7.6.1 MiMedx Group Company Information
7.6.2 MiMedx Group Introduction and Business Overview
7.6.3 MiMedx Group Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.6.4 MiMedx Group Regenerative Medicine Products Product Offerings
7.6.5 MiMedx Group Recent Development
7.7 Organogenesis
7.7.1 Organogenesis Company Information
7.7.2 Organogenesis Introduction and Business Overview
7.7.3 Organogenesis Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Organogenesis Regenerative Medicine Products Product Offerings
7.7.5 Organogenesis Recent Development
7.8 UniQure
7.8.1 UniQure Company Information
7.8.2 UniQure Introduction and Business Overview
7.8.3 UniQure Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.8.4 UniQure Regenerative Medicine Products Product Offerings
7.8.5 UniQure Recent Development
7.9 Cellular Dynamics International
7.9.1 Cellular Dynamics International Company Information
7.9.2 Cellular Dynamics International Introduction and Business Overview
7.9.3 Cellular Dynamics International Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Cellular Dynamics International Regenerative Medicine Products Product Offerings
7.9.5 Cellular Dynamics International Recent Development
7.10 Osiris Therapeutics
7.10.1 Osiris Therapeutics Company Information
7.10.2 Osiris Therapeutics Introduction and Business Overview
7.10.3 Osiris Therapeutics Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Osiris Therapeutics Regenerative Medicine Products Product Offerings
7.10.5 Osiris Therapeutics Recent Development
7.11 Vcanbio
7.11.1 Vcanbio Company Information
7.11.2 Vcanbio Introduction and Business Overview
7.11.3 Vcanbio Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Vcanbio Regenerative Medicine Products Product Offerings
7.11.5 Vcanbio Recent Development
7.12 Gamida Cell
7.12.1 Gamida Cell Company Information
7.12.2 Gamida Cell Introduction and Business Overview
7.12.3 Gamida Cell Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Gamida Cell Regenerative Medicine Products Product Offerings
7.12.5 Gamida Cell Recent Development
7.13 Golden Meditech
7.13.1 Golden Meditech Company Information
7.13.2 Golden Meditech Introduction and Business Overview
7.13.3 Golden Meditech Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Golden Meditech Regenerative Medicine Products Product Offerings
7.13.5 Golden Meditech Recent Development
7.14 Cytori Therapeutics
7.14.1 Cytori Therapeutics Company Information
7.14.2 Cytori Therapeutics Introduction and Business Overview
7.14.3 Cytori Therapeutics Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Cytori Therapeutics Regenerative Medicine Products Product Offerings
7.14.5 Cytori Therapeutics Recent Development
7.15 Celgene
7.15.1 Celgene Company Information
7.15.2 Celgene Introduction and Business Overview
7.15.3 Celgene Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Celgene Regenerative Medicine Products Product Offerings
7.15.5 Celgene Recent Development
7.16 Vericel Corporation
7.16.1 Vericel Corporation Company Information
7.16.2 Vericel Corporation Introduction and Business Overview
7.16.3 Vericel Corporation Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Vericel Corporation Regenerative Medicine Products Product Offerings
7.16.5 Vericel Corporation Recent Development
7.17 Guanhao Biotech
7.17.1 Guanhao Biotech Company Information
7.17.2 Guanhao Biotech Introduction and Business Overview
7.17.3 Guanhao Biotech Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Guanhao Biotech Regenerative Medicine Products Product Offerings
7.17.5 Guanhao Biotech Recent Development
7.18 Mesoblast
7.18.1 Mesoblast Company Information
7.18.2 Mesoblast Introduction and Business Overview
7.18.3 Mesoblast Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Mesoblast Regenerative Medicine Products Product Offerings
7.18.5 Mesoblast Recent Development
7.19 Stemcell Technologes
7.19.1 Stemcell Technologes Company Information
7.19.2 Stemcell Technologes Introduction and Business Overview
7.19.3 Stemcell Technologes Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Stemcell Technologes Regenerative Medicine Products Product Offerings
7.19.5 Stemcell Technologes Recent Development
7.20 Bellicum Pharmaceuticals
7.20.1 Bellicum Pharmaceuticals Company Information
7.20.2 Bellicum Pharmaceuticals Introduction and Business Overview
7.20.3 Bellicum Pharmaceuticals Regenerative Medicine Products Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Bellicum Pharmaceuticals Regenerative Medicine Products Product Offerings
7.20.5 Bellicum Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Regenerative Medicine Products Industrial Chain
8.2 Regenerative Medicine Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Regenerative Medicine Products Sales Model
8.5.2 Sales Channel
8.5.3 Regenerative Medicine Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Acelity
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori Therapeutics
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologes
Bellicum Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.